We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

118 hedge funds and large institutions have $814M invested in Dr. Reddy's Laboratories in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 41

7.7% less ownership

Funds ownership: 76.25% → 68.55% (-7.7%)

8% less funds holding

Funds holding: 128 → 118 (-10)

24% less capital invested

Capital invested by funds: $1.07B → $814M (-$251M)

41% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 22

71% less call options, than puts

Call options by funds: $1.95M | Put options by funds: $6.6M

Holders
118
Holders Change
-10
Holders Change %
-7.81%
% of All Funds
2.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
42
Reduced
41
Closed
22
Calls
$1.95M
Puts
$6.6M
Net Calls
-$4.66M
Net Calls Change
-$4.58M

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$12.1M
2
BlackRock
BlackRock
New York
+$6.77M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$5.51M
4
Jane Street
Jane Street
New York
+$3.77M
5
Citigroup
Citigroup
New York
+$3.56M

Top Sellers

1
CBOA
Commonwealth Bank of Australia
Australia
-$48.4M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$22.5M
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$10.2M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.71M
5
LP
LMR Partners
United Kingdom
-$7.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
BPC
126
Banque Pictet & Cie
Switzerland
– -$624K -75,000 Closed
Artisan Partners
127
Artisan Partners
Wisconsin
– -$573K -67,970 Closed
TI
128
Trexquant Investment
Connecticut
– -$329K -39,000 Closed
SCM
129
Stevens Capital Management
Pennsylvania
– -$309K -36,630 Closed
DTL
130
Dynamic Technology Lab
Singapore
– -$286K -34,000 Closed
Neuberger Berman Group
131
Neuberger Berman Group
New York
– -$282K -33,425 Closed
Wolverine Trading
132
Wolverine Trading
Illinois
– -$252K -30,695 Closed
SG Americas Securities
133
SG Americas Securities
New York
– -$144K -17,085 Closed
SLI
134
Sumitomo Life Insurance
Japan
– -$101K -12,000 Closed
NIPH
135
NN Investment Partners Holdings
Netherlands
– -$77K -9,150 Closed
RFS
136
Rockefeller Financial Services
New York
– -$56K -6,645 Closed
MFBTD
137
MB Financial Bank - Trust Department
Illinois
– -$55K -6,575 Closed
CG
138
Cutler Group
California
– -$10K -1,230 Closed
CTC
139
Central Trust Company
Missouri
– -$8K -1,000 Closed
2 3 4 5
6

RDY Hedge Fund Activity: Q3 2017 in Review

118 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2017, worth a combined $814M — down 24% from $1.07B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of RDY and 13 opened new positions — a net loss of 9 holders — while 41 trimmed existing stakes and 42 added.

The largest buyer was UBS Group, adding an estimated $12.1M. The largest seller was Commonwealth Bank of Australia, cutting an estimated $48.4M.

  • 118 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2017, down from 128 in Q2 2017.
  • Funds reported $814M of Dr. Reddy's Laboratories stock for Q3 2017, down 24% quarter-over-quarter.
  • 13 funds opened new Dr. Reddy's Laboratories positions in Q3 2017 and 22 closed out, a net change of -9 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2017 was UBS Group, an estimated $12.1M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2017 was Commonwealth Bank of Australia, an estimated $48.4M sold.

Based on aggregated 13F filings for Q3 2017.